Form 4: H.B. Fuller Executive VP and CFO Reports Stock Transactions
SEC Form 4 Filing
H.B. Fuller's Executive VP and CFO, John J. Corkrean, reported the acquisition of phantom units and adjustments to holdings of stock options and restricted stock units.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of company securities.
- The filing includes the acquisition of 115.08 phantom units, which convert to common stock on a 1-for-1 basis.
- The report also shows adjustments to holdings of employee stock options and restricted stock units, including those acquired through dividend equivalent reinvestment.
- The transactions were reported as of December 20, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing insider transactions, which is neither positive nor negative in itself. It reflects standard executive compensation practices.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the compensation and holdings of key executives.
Comparison to Industry Standards
- The use of stock options and restricted stock units is a standard practice for executive compensation in publicly traded companies like H.B. Fuller.
- The vesting schedules for stock options and restricted stock units are typical, often spanning several years to align executive interests with long-term company performance.
- Companies like 3M, Sherwin-Williams, and PPG Industries also use similar equity-based compensation methods for their executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
- The transactions do not have a direct impact on employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of grant for an employee stock option with an exercise price of $43.48. |
| 01/26/2018 | Date of grant for an employee stock option with an exercise price of $50.1. |
| 01/25/2019 | Date of grant for an employee stock option with an exercise price of $53.57. |
| 01/24/2020 | Date of grant for an employee stock option with an exercise price of $45.05. |
| 01/24/2021 | Date of grant for an employee stock option with an exercise price of $48.35. |
| 01/24/2023 | Date of grant for an employee stock option with an exercise price of $72.94 and restricted stock units. |
| 01/24/2024 | Date of grant for an employee stock option with an exercise price of $68.17 and restricted stock units. |
| 01/26/2025 | Date of grant for an employee stock option with an exercise price of $77.72 and restricted stock units. |
| 12/20/2024 | Date of the reported transactions, including the acquisition of phantom units. |
| 12/23/2024 | Date of the signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Stock Options, Restricted Stock Units, Phantom Units, H.B. Fuller, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.